Clinical Trials Directory

Trials / Completed

CompletedNCT07524621

The Impact of Nutrition Education and Rice Bran Supplementation on Metabolic Dysfunction-associated Steatotic Liver Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Shih Chien University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the effects of nutrition education with or without rice bran supplementation in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Participants were recruited from the Division of Gastroenterology and Hepatology at Changhua Christian Hospital and assigned to either a nutrition education (NE) group or a nutrition education plus rice bran (NERB) group. The intervention was conducted for a specified study period, during which participants received dietary guidance and follow-up assessments. The primary objective of this study is to determine whether rice bran supplementation in addition to nutrition education provides greater benefits on body weight, body mass index, dietary intake, and metabolic parameters compared with nutrition education alone. Secondary outcomes include changes in liver-related biochemical markers, glycemic indicators, lipid profiles, and other anthropometric measurements. This study may provide evidence on the potential role of rice bran as a functional dietary supplement for improving metabolic health in patients with MASLD and may support the development of practical nutritional strategies for disease management.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNutrition EducationParticipants received structured nutrition education during the study period.
DIETARY_SUPPLEMENTRice BranParticipants received structured nutrition education together with rice bran supplementation during the intervention period.

Timeline

Start date
2021-08-13
Primary completion
2022-06-13
Completion
2023-08-05
First posted
2026-04-13
Last updated
2026-04-13

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07524621. Inclusion in this directory is not an endorsement.